Posted by Michael Wonder on 27 Jun 2018
New from CADTH: procedural guidelines and a streamlined therapeutic review framework
27 June 2018 - Recent changes continue to strengthen the Pharmaceutical Reviews portfolio and help CADTH adapt quickly to the changing pharmaceutical landscape.
Keeping pace with operational changes in CADTH’s Common Drug Review program will now be easier for stakeholders thanks to our newly posted document: Procedure and Submission Guidelines for the CADTH Common Drug Review.
The new guide combines two previously separate documents — Procedure for the CADTH Common Drug Review and Submission Guidelines for the CADTH Common Drug Review — and details how we work with drug manufacturers, as well as the operational procedures to be followed by all participants involved in this process.
